fda bpc 157 unapproved peptide warning bpc-157 safety FDA Targets GLP-1 and Peptide Compounding, Advertising and ' A closer look at the
Description
Dosing ranges from 100-300mcg administered 2-3 times daily, though staying at the lower end helps minimize unwanted hormonal effects

C., Karabulut, A

Berlin H, Berlin R, Brante G (1968) ORAL Treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor

Some community protocols describe drawing the day's dose into a syringe before travel, capping the syringe, and transporting the syringe rather than the vial
